Calcium-mediated dearomatization, C-H bond activation, and allylation of alkylated and benzannulated pyridine derivatives

A facile and general synthetic pathway for the production of dearomatized, allylated, and C? H bond activated pyridine derivatives is presented. Reaction of the corresponding derivative with the previously reported reagent bis(allyl)calcium, [Ca(C₃H₅)₂] ( 1 ), cleanly affords the product in high yield. The range of N‐heterocyclic compounds studied comprised 2‐picoline ( 2 ), 4‐picoline ( 3 ), 2,6‐lutidine ( 4 ), 4‐tert‐butylpyridine ( 5 ), 2,2′‐bipyridine ( 6 ), acridine ( 7 ), quinoline ( 8 ), and isoquinoline ( 9 ). Depending on the substitution pattern of the pyridine derivative, either carbometalation or C? H bond activation products are obtained. In the absence of methyl groups ortho or para to the nitrogen atom, carbometalation leads to dearomatized products. C(sp³)? H bond activation occurs at ortho and para situated methyl groups. Steric shielding of the 4‐position in pyridine yields the ring‐metalated product through C(sp²)? H bond activation instead. The isolated compounds [Ca(2‐CH₂‐C₅H₄N)₂(THF)] ( 2 b ?(THF)), [Ca(4‐CH₂‐C₅H₄N)₂(THF)₂] ( 3 b ?(THF)₂), [Ca(2‐CH₂‐C₅H₃N‐6‐CH₃)₂(THF)_n] ( 4 b ?(THF)_n; n=0, 0.75), [Ca{2‐C₅H₃N‐4‐C(CH₃)₃}₂(THF)₂] ( 5 c ?(THF)₂), [Ca{4,4′‐(C₃H₅)₂‐(C₁₀H₈N₂)}(THF)] ( 6 a ?(THF)), [Ca(NC₁₃H₉‐9‐C₃H₅)₂(THF)] ( 7 a ?(THF)), [Ca(4‐C₃H₅‐C₉H₇N)₂(THF)] ( 8 b ?(THF)), and [Ca(1‐C₃H₅‐C₉H₇N)₂(THF)₃] ( 9 a ?(THF)₃) have been characterized by NMR spectroscopy and metal analysis. 9 a ?(THF)₄ and 4 b ?(THF)₃ were additionally characterized in the solid state by X‐ray diffraction experiments. 4 b ?(THF)₃ shows an aza‐allyl coordination mode in the solid state. Based on the results, mechanistic aspects are discussed in the context of previous findings.     

Cocrystals of 1,4‐diethynylbenzene with 1,3‐diacetylbenzene and benzene‐1,4‐dicarbaldehyde exhibiting strong nonconventional alkyne–carbonyl C—H…O hydrogen bonds between the components

Weak interactions between organic molecules are important in solid‐state structures where the sum of the weaker interactions support the overall three‐dimensional crystal structure. The sp‐C—H…N hydrogen‐bonding interaction is strong enough to promote the deliberate cocrystallization of a series of diynes with a series of dipyridines. It is also possible that a similar series of cocrystals could be formed between molecules containing a terminal alkyne and molecules which contain carbonyl O atoms as the potential hydrogen‐bond acceptor. I now report the crystal structure of two cocrystals that support this hypothesis. The 1:1 cocrystal of 1,4‐diethynylbenzene with 1,3‐diacetylbenzene, C₁₀H₆·C₁₀H₁₀O₂, (1), and the 1:1 cocrystal of 1,4‐diethynylbenzene with benzene‐1,4‐dicarbaldehyde, C₁₀H₆·C₈H₆O₂, (2), are presented. In both cocrystals, a strong nonconventional ethynyl–carbonyl sp‐C—H…O hydrogen bond is observed between the components. In cocrystal (1), the C—H…O hydrogen‐bond angle is 171.8 (16)° and the H…O and C…O hydrogen‐bond distances are 2.200 (19) and 3.139 (2) Å, respectively. In cocrystal (2), the C—H…O hydrogen‐bond angle is 172.5 (16)° and the H…O and C…O hydrogen‐bond distances are 2.25 (2) and 3.203 (2) Å, respectively.     

6‐Propyl‐2‐thiouracil versus 6‐methoxymethyl‐2‐thiouracil: enhancing the hydrogen‐bonded synthon motif by replacement of a methylene group with an O atom

The understanding of intermolecular interactions is a key objective of crystal engineering in order to exploit the derived knowledge for the rational design of new molecular solids with tailored physical and chemical properties. The tools and theories of crystal engineering are indispensable for the rational design of (pharmaceutical) cocrystals. The results of cocrystallization experiments of the antithyroid drug 6‐propyl‐2‐thiouracil (PTU) with 2,4‐diaminopyrimidine (DAPY), and of 6‐methoxymethyl‐2‐thiouracil (MOMTU) with DAPY and 2,4,6‐triaminopyrimidine (TAPY), respectively, are reported. PTU and MOMTU show a high structural similarity and differ only in the replacement of a methylene group (–CH₂–) with an O atom in the side chain, thus introducing an additional hydrogen‐bond acceptor in MOMTU. Both molecules contain an ADA hydrogen‐bonding site (A = acceptor and D = donor), while the coformers DAPY and TAPY both show complementary DAD sites and therefore should be capable of forming a mixed ADA/DAD synthon with each other, i.e. N—H…O, N—H…N and N—H…S hydrogen bonds. The experiments yielded one solvated cocrystal salt of PTU with DAPY, four different solvates of MOMTU, one ionic cocrystal of MOMTU with DAPY and one cocrystal salt of MOMTU with TAPY, namely 2,4‐diaminopyrimidinium 6‐propyl‐2‐thiouracilate–2,4‐diaminopyrimidine–N,N‐dimethylacetamide–water (1/1/1/1) (the systematic name for 6‐propyl‐2‐thiouracilate is 6‐oxo‐4‐propyl‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₇H₉N₂OS⁻·C₄H₆N₄·C₄H₉NO·H₂O, (I), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylformamide (1/1), C₆H₈N₂O₂S·C₃H₇NO, (II), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylacetamide (1/1), C₆H₈N₂O₂S·C₄H₉NO, (III), 6‐methoxymethyl‐2‐thiouracil–dimethyl sulfoxide (1/1), C₆H₈N₂O₂S·C₂H₆OS, (IV), 6‐methoxymethyl‐2‐thiouracil–1‐methylpyrrolidin‐2‐one (1/1), C₆H₈N₂O₂S·C₅H₉NO, (V), 2,4‐diaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate (the systematic name for 6‐methoxymethyl‐2‐thiouracilate is 4‐methoxymethyl‐6‐oxo‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₆H₇N₂O₂S⁻, (VI), and 2,4,6‐triaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate–6‐methoxymethyl‐2‐thiouracil (1/1), C₄H₈N₅⁺·C₆H₇N₂O₂S⁻·C₆H₈N₂O₂S, (VII). Whereas in (I) only an AA/DD hydrogen‐bonding interaction was formed, the structures of (VI) and (VII) both display the desired ADA/DAD synthon. Conformational studies on the side chains of PTU and MOMTU also revealed a significant deviation for cocrystals (VI) and (VII), leading to the desired enhancement of the hydrogen‐bond pattern within the crystal.     

The dinuclear scandium(III) cyclooctatetraenyl chloride complex di‐μ‐chlorido‐bis[(η8‐cyclooctatetraene)(tetrahydrofuran‐κO)scandium(III)]

Only a few cyclooctatetraene dianion (COT) π‐complexes of lanthanides have been crystallographically characterized. This first single‐crystal X‐ray diffraction characterization of a scandium(III) COT chloride complex, namely di‐μ‐chlorido‐bis[(η⁸‐cyclooctatetraene)(tetrahydrofuran‐κO )scandium(III)], [Sc₂(C₈H₈)₂Cl₂(C₄H₈O)₂] or [Sc(COT)Cl(THF)]₂ (THF is tetrahydrofuran), (1), reveals a dimeric molecular structure with symmetric chloride bridges [average Sc—Cl = 2.5972 (7) Å] and a η⁸‐bound COT ligand. The COT ring is planar, with an average C—C bond length of 1.399 (3) Å. The Sc—C bond lengths range from 2.417 (2) to 2.438 (2) Å [average 2.427 (2) Å]. Direct comparison of (1) with the known lanthanide (Ln) analogues (La, Ce, Pr, Nd, and Sm) illustrates the effect of metal‐ion (M ) size on molecular structure. Overall, the M —Cl, M —O, and M —C bond lengths in (1) are the shortest in the series. In addition, only one THF molecule completes the coordination environment of the small Sc^III ion, in contrast to the previously reported dinuclear Ln–COT–Cl complexes, which all have two bound THF molecules per metal atom.     

Scandium complexes with the tetraphenylethylene and anthracene dianions

The structural study of Sc complexes containing dianions of anthracene and tetraphenylethylene should shed some light on the nature of rare‐earth metal–carbon bonding. The crystal structures of (18‐crown‐6)bis(tetrahydrofuran‐κO)sodium bis(η⁶‐1,1,2,2‐tetraphenylethenediyl)scandium(III) tetrahydrofuran disolvate, [Na(C₄H₈O)₂(C₁₂H₂₄O₆)][Sc(C₂₆H₂₀)₂]·2C₄H₈O or [Na(18‐crown‐6)(THF)₂][Sc(η⁶‐C₂Ph₄)₂]·2(THF), ( 1b ), (η⁵‐1,3‐diphenylcyclopentadienyl)(tetrahydrofuran‐κO)(η⁶‐1,1,2,2‐tetraphenylethenediyl)scandium(III) toluene hemisolvate, [Sc(C₁₇H₁₃)(C₂₆H₂₀)(C₄H₈O)]·0.5C₇H₈ or [(η⁵‐1,3‐Ph₂C₅H₃)Sc(η⁶‐C₂Ph₄)(THF)]·0.5(toluene), ( 5b ), poly[[(μ₂‐η³:η³‐anthracenediyl)bis(η⁶‐anthracenediyl)bis(η⁵‐1,3‐diphenylcyclopentadienyl)tetrakis(tetrahydrofuran)dipotassiumdiscandium(III)] tetrahydrofuran monosolvate], {[K₂Sc₂(C₁₄H₁₀)₃(C₁₇H₁₃)₂(C₄H₈O)₄]·C₄H₈O}_n or [K(THF)₂]₂[(1,3‐Ph₂C₅H₃)₂Sc₂(C₁₄H₁₀)₃]·THF, ( 6 ), and 1,4‐diphenylcyclopenta‐1,3‐diene, C₁₇H₁₄, ( 3a ), have been established. The [Sc(η⁶‐C₂Ph₄)₂]⁻ complex anion in ( 1b ) contains the tetraphenylethylene dianion in a symmetrical bis‐η³‐allyl coordination mode. The complex homoleptic [Sc(η⁶‐C₂Ph₄)₂]⁻ anion retains its structure in THF solution, displaying hindered rotation of the coordinated phenyl rings. The 1D ¹H and ¹³C{¹H}, and 2D COSY ¹H–¹H and ¹³C–¹H NMR data are presented for M[Sc(Ph₄C₂)₂]·xTHF [M = Na and x = 4 for ( 1a ); M = K and x = 3.5 for ( 2a )] in THF‐d₈ media. Complex ( 5b ) exhibits an unsymmetrical bis‐η³‐allyl coordination mode of the dianion, but this changes to a η⁴ coordination mode for (1,3‐Ph₂C₅H₃)Sc(Ph₄C₂)(THF)₂, ( 5a ), in THF‐d₈ solution. A ⁴⁵Sc NMR study of ( 2a ) and UV–Vis studies of ( 1a ), ( 2a ) and ( 5a ) indicate a significant covalent contribution to the Sc—Ph₄C₂ bond character. The unique Sc ate complex, ( 6 ), contains three anthracenide dianions demonstrating both a η⁶‐coordination mode for two bent ligands and a μ₂‐η³:η³‐bridging mode of a flat ligand. Each [(1,3‐Ph₂C₅H₃)₂Sc₂(C₁₄H₁₀)₃]²⁻ dianionic unit is connected to four neighbouring units via short contacts with [K(THF)₂]⁺ cations, forming a two‐dimensional coordination polymer framework parallel to (001).     

Two N‐(2‐phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents

Notwithstanding its simple structure, the chemistry of nitric oxide (NO) is complex. As a radical, NO is highly reactive. NO also has profound effects on the cardiovascular system. In order to regulate NO levels, direct therapeutic interventions include the development of numerous NO donors. Most of these donors release NO in a single high‐concentration burst, which is deleterious. N‐Nitrosated secondary amines release NO in a slow, sustained, and rate‐tunable manner. Two new precursors to sustained NO‐releasing materials have been characterized. N‐[2‐(3,4‐Dimethoxyphenyl)ethyl]‐2,4‐dinitroaniline, C₁₆H₁₇N₃O₆, (I), crystallizes with one independent molecule in the asymmetric unit. The adjacent amine and nitro groups form an intramolecular N—H…O hydrogen bond. The anti conformation about the phenylethyl‐to‐aniline C—N bond leads to the planes of the arene and aniline rings being approximately perpendicular. Molecules are linked into dimers by weak intermolecular N—H…O hydrogen bonds such that each amine H atom participates in a three‐center interaction with two nitro O atoms. The dimers pack so that the arene rings of adjacent molecules are not parallel and π–π interactions do not appear to be favored. N‐(4‐Methylsulfonyl‐2‐nitrophenyl)‐l ‐phenylalanine, C₁₆H₁₆N₂O₆S, (II), with an optically active center, also crystallizes with one unique molecule in the asymmetric unit. The l enantiomer was established via the configuration of the starting material and was confirmed by refinement of the Flack parameter. As in (I), there is an intramolecular N—H…O hydrogen bond between adjacent amine and nitro groups. The conformation of the molecule is such that the arene rings display a dihedral angle of ca 60°. Unlike (I), molecules are not linked via intermolecular N—H…O hydrogen bonds. Rather, the carboxylic acid H atom forms a classic, approximately linear, O—H…O hydrogen bond with a sulfone O atom. Pairs of molecules related by twofold rotation axes are linked into dimers by two such interactions. The packing pattern features a zigzag arrangement of the arene rings without apparent π–π interactions. These structures are compared with reported analogues, revealing significant differences in molecular conformation, intermolecular interactions, and packing that result from modest changes in functional groups. The structures are discussed in terms of potential NO‐release capability.     

Tetrakis­(tetra­hydro­furan‐κO)­lithium mer‐tris­(carbazolyl‐κN)‐trans‐di­chloro(tetra­hydro­furan‐κO)­zirconate

In the title compound, [Li(C₄H₈O)₄][ZrCl₂(C₁₂H₈N)₃(C₄H₈O)], the environment of the Zr atom is pseudo‐octahedral, with the three carbazolyl ligands in a mer configuration. The counter‐ion of the zirconium complex is composed of an Li atom surrounded by four tetra­hydro­furan (THF) mol­ecules. The THF mol­ecule attached to the Zr atom is disordered over two sites, as are two of the THF mol­ecules in the lithium moiety. All bond distances and angles are consistent with those in complexes with similar structural entities. The Zr—N bond distances are 2.2185 (18) and 2.167 (3) Å.     

Two Fe3(μ3‐S)2(CO)8 clusters with terminal N‐heterocyclic carbenes

The title compounds with terminal N‐heterocyclic carbenes, namely octacarbonyl(imidazolidinylidene‐κC²)di‐μ₃‐sulfido‐triiron(II)(2 Fe—Fe), [Fe₃(C₃H₆N₂)(μ₃‐S)₂(CO)₈], (I), and octacarbonyl(1‐methylimidazo[1,5‐a]pyridin‐3‐ylidene‐κC³)di‐μ₃‐sulfido‐triiron(II)(2 Fe—Fe), [Fe₃(C₈H₈N₂)(μ₃‐S)₂(CO)₈], (II), have been synthesized. Each compound contains two Fe—Fe bonds and two S atoms above and below a triiron triangle. One of the eight carbonyl ligands deviates significantly from linearity. In (I), dimers generated by an N—H...S hydrogen bond are linked into [001] double chains by a second N—H...S hydrogen bond. These chains are packed by a C—H...O hydrogen bond to yield [101] sheets. In (II), dimers generated by an N—H...S hydrogen bond are linked by C—H...O hydrogen bonds to form [111] double chains.     

Crystallographic report: Crystal structure of bis(2,4,6‐tri‐tert‐butylphenolato‐O) bis(tetrahydrofuran‐O) samarium (N,N‐η2‐azobenzene) diethyl ether solvate

Reaction of divalent Sm(OAr)₂(THF)₃ (Ar = C₆H₂‐tert‐Bu₃‐2,4,6; THF = tetrahydrofuran) with one equivalent of azobenzene in THF and crystallization of the product in diethyl ether afforded the title complex (ArO)₂(THF)₂Sm(η²‐N₂Ph₂)·Et₂O in good yield. In the complex, the N? N bond length for the azobenzene species is lengthened. The two Sm? N bonds are equivalent, and their bond lengths are intermediate between the donor bond and the single bond. Copyright © 2005 John Wiley & Sons, Ltd.     

o‐ and m‐Benzenedicarbaldehyde

o‐Benzene­dicarb­aldehyde (systematic name: benzene‐1,2‐dicarb­aldehyde), C₈H₆O₂, exhibits a weak intramolecular hydrogen bond between an aldehyde H atom and the O atom of the adjacent aldehyde group, with a C?O distance of 2.852 (2) Å. m‐Benzene­dicarb­aldehyde (systematic name: benzene‐1,3‐dicarb­aldehyde), C₈H₆O₂, occurs as two different isomorphs. In all three crystals, there are intermolecular C—­H?O contacts involving both aldehyde and ring H atoms.     

One barbiturate and two solvated thiobarbiturates containing the triply hydrogen‐bonded ADA/DAD synthon,plus one ansolvate and three solvates of their coformer 2,4‐diaminopyrimidine

A path to new synthons for application in crystal engineering is the replacement of a strong hydrogen‐bond acceptor, like a C=O group, with a weaker acceptor, like a C=S group, in doubly or triply hydrogen‐bonded synthons. For instance, if the C=O group at the 2‐position of barbituric acid is changed into a C=S group, 2‐thiobarbituric acid is obtained. Each of the compounds comprises two ADA hydrogen‐bonding sites (D = donor and A = acceptor). We report the results of cocrystallization experiments of barbituric acid and 2‐thiobarbituric acid, respectively, with 2,4‐diaminopyrimidine, which contains a complementary DAD hydrogen‐bonding site and is therefore capable of forming an ADA/DAD synthon with barbituric acid and 2‐thiobarbituric acid. In addition, pure 2,4‐diaminopyrimidine was crystallized in order to study its preferred hydrogen‐bonding motifs. The experiments yielded one ansolvate of 2,4‐diaminopyrimidine (pyrimidine‐2,4‐diamine, DAPY), C₄H₆N₄, (I), three solvates of DAPY, namely 2,4‐diaminopyrimidine–1,4‐dioxane (2/1), 2C₄H₆N₄·C₄H₈O₂, (II), 2,4‐diaminopyrimidine–N,N‐dimethylacetamide (1/1), C₄H₆N₄·C₄H₉NO, (III), and 2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1), C₄H₆N₄·C₅H₉NO, (IV), one salt of barbituric acid, viz. 2,4‐diaminopyrimidinium barbiturate (barbiturate is 2,4,6‐trioxopyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₃⁻, (V), and two solvated salts of 2‐thiobarbituric acid, viz. 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylformamide (1/2) (2‐thiobarbiturate is 4,6‐dioxo‐2‐sulfanylidenepyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₃H₇NO, (VI), and 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylacetamide (1/2), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₄H₉NO, (VII). The ADA/DAD synthon was succesfully formed in the salt of barbituric acid, i.e. (V), as well as in the salts of 2‐thiobarbituric acid, i.e. (VI) and (VII). In the crystal structures of 2,4‐diaminopyrimidine, i.e. (I)–(IV), R₂²(8) N—H…N hydrogen‐bond motifs are preferred and, in two structures, additional R₃²(8) patterns were observed.     

Synthesis and Structure of 1—Cyclopentylindenyl Lanthanide（Ⅱ）Complexes and Their Catalytic Behavior for Polymerization of Acrylonitrile

The reaction between K(1‐C₅H₉C₉H₆) and anhydrous LnCl₃ (Ln=Sm, Yb) in the molar ratio of 2:1 in THF with subsequent treatment by Na‐K alloy afforded (1‐C₅H₉C₉H₆)₂Ln‐(THF)_n(Ln=Sm, n=1; Ln=Yb, n=2), while the reaction of Sml₂ with K(1‐C₅H₉C₉H₆) in the molar ratio of 1:2 in THF gave the anionic complex K(1‐C₅H₉C₉H₆)₃Sm(THF)₃. The X‐ray structure of (1‐C₅H₉C₉H₆)₂Yb(THF)₂ showed that central metal Yb is coordinated by two cyclopentadienyl rings of 1‐cyclopentylindenyls and two oxygen atoms from two tetrahydrofuran molecules to form pseudo‐tetrahedral coordinate geometry. All these complexes are active for the polymerization of acrylonitrile.     

6‐Chloroisocytosine and 5‐bromo‐6‐methylisocytosine: again,one or two tautomers present in the same crystal?

It is well known that pyrimidin‐4‐one derivatives are able to adopt either the 1H‐ or the 3H‐tautomeric form in (co)crystals, depending on the coformer. As part of ongoing research to investigate the preferred hydrogen‐bonding patterns of active pharmaceutical ingredients and their model systems, 2‐amino‐6‐chloropyrimidin‐4‐one and 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4‐one have been cocrystallized with several coformers and with each other. Since Cl and Br atoms both have versatile possibilities to interact with the coformers, such as via hydrogen or halogen bonds, their behaviour within the crystal packing was also of interest. The experiments yielded five crystal structures, namely 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (1/3), C₅H₇N₂⁺·C₄H₃ClN₃O⁻·3C₄H₄ClN₃O, (Ia), 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one–2‐aminopyridine (2/10/1), 2C₅H₇N₂⁺·2C₄H₃ClN₃O⁻·10C₄H₄ClN₃O·C₅H₆N₂, (Ib), the solvent‐free cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one (1/1), C₅H₆BrN₃O·C₅H₆BrN₃O, (II), the solvate 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₆BrN₃O·C₅H₆BrN₃O·C₅H₉NO, (III), and the partial cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (0.635/1/0.365), C₅H₆BrN₃O·C₅H₆BrN₃O·C₄H₄ClN₃O, (IV). All five structures show R₂²(8) hydrogen‐bond‐based patterns, either by synthon 2 or by synthon 3, which are related to the Watson–Crick base pairs.     

N—H...O and O—H...O hydrogen‐bonded supramolecular networks in 4‐chloroanilinium, 2‐hydroxyanilinium and 3‐hydroxyanilinium hydrogen phthalates

The title salts, 4‐chloroanilinium hydrogen phthalate (PCAHP), C₆H₇ClN⁺·C₈H₅O₄⁻, 2‐hydroxyanilinium hydrogen phthalate (2HAHP), C₆H₈NO⁺·C₈H₅O₄⁻, and 3‐hydroxyanilinium hydrogen phthalate (3HAHP), C₆H₈NO⁺·C₈H₅O₄⁻, all crystallize in the space group P2₁/c. The asymmetric unit of 2HAHP contains two independent ion pairs. The hydrogen phthalate ions of 2HAHP and 3HAHP show a short intramolecular O—H...O hydrogen bond, with O...O distances ranging from 2.3832 (15) to 2.3860 (14) Å. N—H...O and O—H...O hydrogen bonds, together with short C—H...O contacts in PCAHP and 3HAHP, generate extended hydrogen‐bond networks. PCAHP forms a two‐dimensional supramolecular sheet extending in the (100) plane, whereas 2HAHP has a supramolecular chain running parallel to the [100] direction and 3HAHP has a two‐dimensional network extending parallel to the (001) plane.     

3‐Cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone: two new pseudopolymorphs and two cocrystals with products of an in situ nucleophilic aromatic substitution

Four crystal structures of 3‐cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone (CMP), viz. the dimethyl sulfoxide monosolvate, C₇H₆N₂O₂·C₂H₆OS, (1), the N,N‐dimethylacetamide monosolvate, C₇H₆N₂O₂·C₄H₉NO, (2), a cocrystal with 2‐amino‐4‐dimethylamino‐6‐methylpyrimidine (as the salt 2‐amino‐4‐dimethylamino‐6‐methylpyrimidin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate), C₇H₁₃N₄⁺·C₇H₅N₂O₂⁻, (3), and a cocrystal with N,N‐dimethylacetamide and 4,6‐diamino‐2‐dimethylamino‐1,3,5‐triazine [as the solvated salt 2,6‐diamino‐4‐dimethylamino‐1,3,5‐triazin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate–N,N‐dimethylacetamide (1/1)], C₅H₁₁N₆⁺·C₇H₅N₂O₂⁻·C₄H₉NO, (4), are reported. Solvates (1) and (2) both contain the hydroxy group in a para position with respect to the cyano group of CMP, acting as a hydrogen‐bond donor and leading to rather similar packing motifs. In cocrystals (3) and (4), hydrolysis of the solvent molecules occurs and an in situ nucleophilic aromatic substitution of a Cl atom with a dimethylamino group has taken place. Within all four structures, an R₂²(8) N—H...O hydrogen‐bonding pattern is observed, connecting the CMP molecules, but the pattern differs depending on which O atom participates in the motif, either the ortho or para O atom with respect to the cyano group. Solvents and coformers are attached to these arrangements via single‐point O—H...O interactions in (1) and (2) or by additional R₄⁴(16) hydrogen‐bonding patterns in (3) and (4). Since the in situ nucleophilic aromatic substitution of the coformers occurs, the possible Watson–Crick C–G base‐pair‐like arrangement is inhibited, yet the cyano group of the CMP molecules participates in hydrogen bonds with their coformers, influencing the crystal packing to form chains.     

Peptide cation-radicals. A computational study of the competition between peptide N-Calpha bond cleavage and loss of the side chain in the [GlyPhe-NH2 + 2H]+. cation-radical

Cation‐radicals and dications corresponding to hydrogen atom adducts to N‐terminus‐protonated N_α‐glycylphenylalanine amide (Gly‐Phe‐NH₂) are studied by combined density functional theory and Møller‐Plesset perturbational computations (B3‐MP2) as models for electron‐capture dissociation of peptide bonds and elimination of side‐chain groups in gas‐phase peptide ions. Several structures are identified as local energy minima including isomeric aminoketyl cation‐radicals, and hydrogen‐bonded ion‐radicals, and ylid‐cation‐radical complexes. The hydrogen‐bonded complexes are substantially more stable than the classical aminoketyl structures. Dissociations of the peptide N? C_α bonds in aminoketyl cation‐radicals are 18–47 kJ mol^?1 exothermic and require low activation energies to produce ion‐radical complexes as stable intermediates. Loss of the side‐chain benzyl group is calculated to be 44 kJ mol^?1 endothermic and requires 68 kJ mol^?1 activation energy. Rice‐Ramsperger‐Kassel‐Marcus (RRKM) and transition‐state theory (TST) calculations of unimolecular rate constants predict fast preferential N? C_α bond cleavage resulting in isomerization to ion‐molecule complexes, while dissociation of the C_α? CH₂C₆H₅ bond is much slower. Because of the very low activation energies, the peptide bond dissociations are predicted to be fast in peptide cation‐radicals that have thermal (298 K) energies and thus behave ergodically. Copyright © 2003 John Wiley & Sons, Ltd.     

Potassium hydrogen trans‐glutaconate monohydrate at 295, 245 and 40 K,and its rubidium analogue at 298 K

A centrosymmetric and short O—H?O hydrogen bond was found in isomorphic crystals of potassium hydrogen trans‐glutaconate monohydrate (potassium hydrogen trans‐pent‐2‐ene‐1,5‐dioate, K⁺·C₅H₅O₄^?·H₂O), (I), and rubidium hydrogen trans‐glutaconate monohydrate (rubidium hydrogen trans‐pent‐2‐ene‐1,5‐dioate, Rb⁺·C₅H₅O₄^?·H₂O), (II). The O?O distance at room temperature is 2.444 (3) Å in (I), and 2.417 (4) Å in (II). The O?O distance for (I) showed no significant decrease at low temperatures.     

Five pseudopolymorphs of 6‐amino‐2‐thiouracil: absence of N—H...S hydrogen bonds

In order to study the preferred hydrogen‐bonding pattern of 6‐amino‐2‐thiouracil, C₄H₅N₃OS, (I), crystallization experiments yielded five different pseudopolymorphs of (I), namely the dimethylformamide disolvate, C₄H₅N₃OS·2C₃H₇NO, (Ia), the dimethylacetamide monosolvate, C₄H₅N₃OS·C₄H₉NO, (Ib), the dimethylacetamide sesquisolvate, C₄H₅N₃OS·1.5C₄H₉NO, (Ic), and two different 1‐methylpyrrolidin‐2‐one sesquisolvates, C₄H₅N₃OS·1.5C₅H₉NO, (Id) and (Ie). All structures contain R₂¹(6) N—H...O hydrogen‐bond motifs. In the latter four structures, additional R₂²(8) N—H...O hydrogen‐bond motifs are present stabilizing homodimers of (I). No type of hydrogen bond other than N—H...O is observed. According to a search of the Cambridge Structural Database, most 2‐thiouracil derivatives form homodimers stabilized by an R₂²(8) hydrogen‐bonding pattern, with (i) only N—H...O, (ii) only N—H...S or (iii) alternating pairs of N—H...O and N—H...S hydrogen bonds.     

Ethyl­ammonium and diethyl­ammonium salts of chloranilic acid

In the crystals of two title salts of chloranilic acid (2,5‐di­chloro‐3,6‐di­hydroxy‐p‐benzo­quinone), namely ethyl­ammonium chloranilate, C₂H₈N⁺·C₆HCl₂O₄^?, (I), and diethyl­ammonium chloranilate, C₄H₁₂N⁺·C₆HCl₂O₄^?, (II), the chloranilate ions are present as a hydrogen‐bonded dimer which has an inversion center. The ethyl­ammonium and diethyl­ammonium ions link the dimers through N—H?O hydrogen bonds, forming a three‐dimensional hydrogen‐bond network in (I) and a one‐dimensional chain in (II).     

A structural study of 4‐aminoantipyrine and six of its Schiff base derivatives

Six derivatives of 4‐amino‐1,5‐dimethyl‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐3‐one (4‐aminoantipyrine), C₁₁H₁₃N₃O, (I), have been synthesized and structurally characterized to investigate the changes in the observed hydrogen‐bonding motifs compared to the original 4‐aminoantipyrine. The derivatives were synthesized from the reactions of 4‐aminoantipyrine with various aldehyde‐, ketone‐ and ester‐containing molecules, producing (Z)‐methyl 3‐[(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)amino]but‐2‐enoate, C₁₆H₁₉N₃O₃, (II), (Z)‐ethyl 3‐[(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)amino]but‐2‐enoate, C₁₇H₂₁N₃O₃, (III), ethyl 2‐[(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)amino]cyclohex‐1‐enecarboxylate, C₂₀H₂₅N₃O₃, (IV), (Z)‐ethyl 3‐[(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)amino]‐3‐phenylacrylate, C₂₂H₂₃N₃O₃, (V), 2‐cyano‐N‐(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)acetamide, C₁₄H₁₄N₄O₂, (VI), and (E)‐methyl 4‐{[(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)amino]methyl}benzoate, C₂₀H₁₉N₃O₃, (VII). The asymmetric units of all these compounds have one molecule on a general position. The hydrogen bonding in (I) forms chains of molecules via intermolecular N—H...O hydrogen bonds around a crystallographic sixfold screw axis. In contrast, the formation of enamines for all derived compounds except (VII) favours the formation of a six‐membered intramolecular N—H...O hydrogen‐bonded ring in (II)–(V) and an intermolecular N—H...O hydrogen bond in (VI), whereas there is an intramolecular C—H...O hydrogen bond in the structure of imine (VII). All the reported compounds, except for (II), feature π–π interactions, while C—H...π interactions are observed in (II), C—H...O interactions are observed in (I), (III), (V) and (VI), and a C—O...π interaction is observed in (II).